News Rising UK drugs bill raises fears of price controls Higher than expected growth in the branded medicines bill has caused the UK government to consider price cuts.
News A vote of no confidence in UK's pricing system The new PPRS is not good news for all pharma companies, concludes industry audience
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
